Fundraising Fox

PainTEQ

2 known investors

PainTEQ develops minimally invasive implants (LINQ and TRAQ) made of treated, sterile bone for treating sacroiliac (SI) joint pain, positioned between conservative treatments and major surgery. Its products are used by physicians to treat patients with chronic SI joint-related low back pain.

HealthtechMedical Devices

Investors · 2

Signet Healthcare PartnersNew York · $10M – $50M
Windham Capital PartnersNew York · $1M – $5M

Funding

SEC filings, press & company announcements

$35M disclosed across 1 of 3 rounds · 2023–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

PainTEQ: Funding Raised To Advance Minimally Invasive SI Joint Solutionspulse2.com · Aug 2025PainTEQ Secures Majority Growth Recapitalization Co-Led by Signet Healthcare Partners & Windham Capital Partnersfinance.yahoo.com · Aug 2025MedTech Company, PainTEQ, Raises $35M Capital Infusion - The MedTech Digestthemedtechdigest.com · Aug 2023Tampa medical device firm picks up $35 million investment | Business Observerbusinessobserverfl.com · Jul 2023Spine fusion company PainTEQ raises $35Mmassdevice.com · Jul 2023PainTEQ Raises $35 Million in Non-Dilutive IP-Backed Financing, Fueling Market Expansion and Innovationprnewswire.com · Jul 2023

Frequently asked questions

What does PainTEQ do?
PainTEQ develops minimally invasive implants (LINQ and TRAQ) made of treated, sterile bone for treating sacroiliac (SI) joint pain, positioned between conservative treatments and major surgery. Its products are used by physicians to treat patients with chronic SI joint-related low back pain.
Who are PainTEQ's investors?
PainTEQ's investors include Signet Healthcare Partners, Windham Capital Partners.
How much funding has PainTEQ raised?
PainTEQ has disclosed $35M raised across 1 of its 3 known rounds.